David McLaughlin
CEO and founderDavid McLaughlin is CEO and founder of QuantaVerse
David McLaughlin is CEO and founder of QuantaVerse
Letters and e-mails between the two companies may become evidence in the Justice Department’s lawsuit seeking to halt the $48 billion.
The decision on the trial’s timing comes after the DOJ tried to persuade a U.S. District judge to delay the start until January, after the companies’ self-imposed merger deadline.
The judge overseeing two U.S. cases challenging mergers among four of the biggest health insurers gave up one, improving the odds for rulings on both tie-ups by the end of the year and reducing the chance they fall apart beforehand.
The takeover is in “danger of collapsing” unless there’s a quick trial to resolve a U.S. lawsuit seeking to block the deal.
U.S. antitrust enforcers roundly rejected a pair of proposed deals that would consolidate the nation’s five biggest health insurers into three.
With Aetna Inc. and Humana Inc. pairing off, pressure is mounting on other major health insurers to make their own deals.